ChemGenex Gets Approval to Demerge Verva Pharma

ChemGenex Pharmaceuticals Limited has said that it received shareholder approval to demerge its metabolic diseases business, Autogen Research Limited, which is to be renamed Verva Pharmaceuticals Limited.
BioSpectrum